Prices for site licence access to The EMBO Journal and EMBO reports will be reduced by 9% in 2010, reflecting the increased publication of Open Access content in 2008. Nature Publishing Group (NPG) and the European Molecular Biology Organisation (EMBO) announced the decision today, following ratification by the EMBO Council.

For the 2010 subscription year, there will be a 9% reduction on the 2009 site licence list price. This reduction is net of an annual inflationary price increase. Print and personal subscription prices are unaffected.

For the 2011 subscription year onwards, both the site licence price and author fees will be considered in an effort to achieve equitable distribution of the costs of publication. This evaluation will involve an in-depth review of all factors relevant to the publication process, including the proportion of Open Access content and authors’ ability to pay for Open Access and other publication-related costs.

 NPG publishes and EMBO reports on behalf of EMBO. An Open Access option on both journals was introduced in January 2007. NPG has implemented hybrid models across many of its academic journals, and expects those titles to show price reductions in due course, as the volume of open access increases.

NPG will be contacting customers individually. Customers who have already paid for a 2010 subscription should contact their NPG sales representative or subscription agent to claim an adjustment.

Grace Baynes
Corporate Public Relations, Nature Publishing Group
T:+44 (0)20 7014 4063